Several brands of diet and “detox” tea have been withdrawn from sale after Consumer NZ found they contained a pharmacy-only medicine.
Consumer NZ chief executive Sue Chetwin said the teas contained senna, a source of sennosides, which are used to treat constipation.
Companies need consent from Medsafe to advertise or sell products containing senna. However, none of the teas had this approval.
Ms Chetwin said it was concerning companies didn’t appear to be aware of the rules. Senna can lead to liver damage if taken for too long, she said.
The brands found by Consumer NZ included Healtheries Naturally Slim teas, sold at supermarkets.
Three Healtheries teas were removed from sale following Consumer NZ’s investigation: Healtheries Naturally Slim Lemon Tea, Healtheries Naturally Slim Superfruit Acai and Blueberry Tea, and Healtheries Herbalax Senna Peppermint Tea.
Other teas removed from sale included Senna Klenz, promoted as a detox tea and sold at health food stores, and a senna “teatox” advertised by influencer and personal trainer Sera Lilly on her website fat2fitnz.co.nz.
“These types of products make various claims about weight loss or ‘detoxing’ but they can be little more than laxatives in disguise,” Ms Chetwin said.
She advised consumers not to waste money on diet and detox teas. “There’s no good evidence these products provide any benefits and they could even do you harm.”
Detox claims were also meaningless, she said. “You don’t need to buy a pricey tea to ‘detox’. Your body is already primed to get rid of toxins by itself.”
Advertising or selling pharmacy-only medicines, such as senna, without consent can result in a fine of up to $100,000.
Consumer NZ is a non-profit organisation, celebrating our 60th year of helping New Zealanders get a fairer deal. In addition to our product tests, we investigate consumer issues and campaign to improve consumer rights. But we're not government-funded and don't take advertising, so we rely on revenue generated from membership to fund our work. Consider supporting us today. Join us, and become a member at consumer.org.nz.
Tickets for all shows go on sale at 12pm Friday, January 24.
My Live Nation members may also secure tickets first during the pre-sale beginning 12pm Thursday, January 23 until 11am Friday, January 24.
For complete tour and ticket information, visit: livenation.co.nz.
The lauded Icelandic artist makes music that penetrates a little deeper than most. As a potent Icelandic songwriter, his debut album soared to success in his native land, before English language edition 'In The Silence' connected with an entirely new audience. An artist of rare scope, sincerity, and emotion, his next step might well be his bravest, and his most enduring. 'Bury The Moon' – or 'Sátt', to give the record its Icelandic title – begins with escape. Ásgeir left Reykjavik to go and write at a friend's summerhouse in the Icelandic countryside. He spent the winter writing, just himself and his guitar, abandoning the studio set up and full band affair that produced his sophomore album, 'Afterglow'.
At times, 'Bury The Moon' is a bruising, achingly personal experience, with shades of the endless isolation Ásgeir put himself through in that remote summerhouse.
In accepting his own imperfections, Ásgeir may well have produced his most remarkable work yet and New Zealand fans will be among the first to experience his newest album. Don't miss Ásgeir – live in Wellington and Auckland this May.
New Zealand 2020
FRIDAY MAY 8
SATURDAY MAY 9
TICKETS ON SALE 12PM FRIDAY, JANUARY 24
Live Nation pre-sale begins 12pm Thursday, January 23 until 11am Friday, January 24
For complete tour and ticket information, visit:
asgeirmusic.com & livenation.co.nz
Source: Reserve Bank of New Zealand
The aggregate solvency ratio of New Zealand's life insurance sector has declined in recent years, raising questions about the ability of some insurers to cope in the event of an adverse shock.
These factors and more are explored in the Reserve Bank's latest Bulletin article by Financial System Analyst Jinny Leong.
Life insurance coverage softens the financial impact of events such as death, disablement and major illness, allowing insured individuals and their families to maintain their living standards. However, life insurance penetration in New Zealand is well below the OECD average, which may be partly explained by the low proportion of savings products in New Zealand and New Zealanders' reliance on the government (ACC cover) to mitigate some risks that would otherwise be in the purview of the life insurance sector, Miss Leong writes.
New Zealand life insurers have a return on equity higher than the median, even after allowing for high expenses. The high expenses are driven by high commission rates, soft commissions, some policy replacement activity and a lack of scale. High expenses have a detrimental impact on premium affordability and value for money for policyholders.
The aggregate solvency ratio for the life insurance sector has declined in recent years and is low relative to other countries. Some life insurers operate with low solvency margins over the regulatory minimum, raising questions about their ability to comfortably meet the minimum requirements in the event of an adverse shock, such as further sharp falls in long-term interest rates.
The Reserve Bank began regulating and supervising insurers from 2011 after the Insurance (Prudential Supervision) Act 2010 (IPSA) came into force. The Act is being reviewed by the Reserve Bank, with further information to follow later this year. Alongside the forthcoming review of IPSA, the Reserve Bank will review solvency standards and consider the case for solvency buffers, with the aim of improving resilience in the sector.